Risk prediction models for heart failure admissions in adults with congenital heart disease.


Journal

International journal of cardiology
ISSN: 1874-1754
Titre abrégé: Int J Cardiol
Pays: Netherlands
ID NLM: 8200291

Informations de publication

Date de publication:
01 01 2021
Historique:
received: 12 04 2020
revised: 04 07 2020
accepted: 07 08 2020
pubmed: 18 8 2020
medline: 28 5 2021
entrez: 18 8 2020
Statut: ppublish

Résumé

Heart failure (HF) is the leading cause of death in adult patients with congenital heart disease (ACHD). No risk prediction model exists for HF hospitalization (HFH) for ACHD patients. We aimed to develop a clinically relevant one-year risk prediction system to identify ACHD patients at high risk for HFH. Data source was the Quebec CHD Database. A retrospective cohort including all ACHD patients aged 18-64 (1995-2010) was constructed for assessing the cumulative risk of HFH adjusting for competing risk of death. To identify one-year predictors of incident HFH, multivariable logistic regressions were employed to a nested case-control sample of all ACHD patients aged 18-64 in 2009. The final model was used to create a risk score system based on adjusted odds ratios. The cohort included 29,991 ACHD patients followed for 648,457 person-years. The cumulative HFH risk by age 65 was 12.58%. The case-control sample comprised 26,420 subjects, of whom 189 had HFHs. Significant one-year predictors were age ≥ 50, male sex, CHD lesion severity, recent 12-month HFH history, pulmonary arterial hypertension, chronic kidney disease, coronary artery disease, systemic arterial hypertension, and diabetes mellitus. The created risk score ranged from 0 to 19. The corresponding HFH risk rose rapidly beyond a score of 8. The risk scoring system demonstrated excellent prediction performance. One eighth of ACHD population experienced HFH before age 65. Age, sex, CHD lesion severity, recent 12-month HFH history, and comorbidities constructed a risk prediction model that successfully identified patients at high risk for HFH.

Sections du résumé

BACKGROUND
Heart failure (HF) is the leading cause of death in adult patients with congenital heart disease (ACHD). No risk prediction model exists for HF hospitalization (HFH) for ACHD patients. We aimed to develop a clinically relevant one-year risk prediction system to identify ACHD patients at high risk for HFH.
METHODS
Data source was the Quebec CHD Database. A retrospective cohort including all ACHD patients aged 18-64 (1995-2010) was constructed for assessing the cumulative risk of HFH adjusting for competing risk of death. To identify one-year predictors of incident HFH, multivariable logistic regressions were employed to a nested case-control sample of all ACHD patients aged 18-64 in 2009. The final model was used to create a risk score system based on adjusted odds ratios.
RESULTS
The cohort included 29,991 ACHD patients followed for 648,457 person-years. The cumulative HFH risk by age 65 was 12.58%. The case-control sample comprised 26,420 subjects, of whom 189 had HFHs. Significant one-year predictors were age ≥ 50, male sex, CHD lesion severity, recent 12-month HFH history, pulmonary arterial hypertension, chronic kidney disease, coronary artery disease, systemic arterial hypertension, and diabetes mellitus. The created risk score ranged from 0 to 19. The corresponding HFH risk rose rapidly beyond a score of 8. The risk scoring system demonstrated excellent prediction performance.
CONCLUSIONS
One eighth of ACHD population experienced HFH before age 65. Age, sex, CHD lesion severity, recent 12-month HFH history, and comorbidities constructed a risk prediction model that successfully identified patients at high risk for HFH.

Identifiants

pubmed: 32798623
pii: S0167-5273(20)33566-X
doi: 10.1016/j.ijcard.2020.08.039
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

149-157

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors report no relationships that could be construed as a conflict of interest.

Auteurs

Sarah Cohen (S)

McGill Adult Unit for Congenital Heart Disease Excellence, Montréal, Québec, Canada.

Aihua Liu (A)

McGill Adult Unit for Congenital Heart Disease Excellence, Montréal, Québec, Canada.

Fei Wang (F)

McGill Adult Unit for Congenital Heart Disease Excellence, Montréal, Québec, Canada; Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montréal, Québec, Canada.

Liming Guo (L)

McGill Adult Unit for Congenital Heart Disease Excellence, Montréal, Québec, Canada.

James M Brophy (JM)

Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montréal, Québec, Canada; Division of Cardiology, McGill University Health Centre, Canada.

Michal Abrahamowicz (M)

Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montréal, Québec, Canada.

Judith Therrien (J)

McGill Adult Unit for Congenital Heart Disease Excellence, Montréal, Québec, Canada.

Luc M Beauchesne (LM)

Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; iCACH Net Group (Canadian Adult Congenital Heart Disease Network Investigators' Group), Canada.

Elisabeth Bédard (E)

Quebec Heart & Lung Institute, Laval University, Quebec City, Québec, Canada; iCACH Net Group (Canadian Adult Congenital Heart Disease Network Investigators' Group), Canada.

Jasmine Grewal (J)

Division of Cardiology, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada; iCACH Net Group (Canadian Adult Congenital Heart Disease Network Investigators' Group), Canada.

Paul Khairy (P)

Montréal Heart Institute, Université de Montréal, Montréal, Québec, Canada; iCACH Net Group (Canadian Adult Congenital Heart Disease Network Investigators' Group), Canada.

Erwin Oechslin (E)

Toronto Congenital Cardiac Centre for Adults, Peter Munk Cardiac Centre, University Health Network, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada; iCACH Net Group (Canadian Adult Congenital Heart Disease Network Investigators' Group), Canada.

S Lucy Roche (SL)

Toronto Congenital Cardiac Centre for Adults, Peter Munk Cardiac Centre, University Health Network, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada; iCACH Net Group (Canadian Adult Congenital Heart Disease Network Investigators' Group), Canada.

Candice K Silversides (CK)

Toronto Congenital Cardiac Centre for Adults, Peter Munk Cardiac Centre, University Health Network, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada; iCACH Net Group (Canadian Adult Congenital Heart Disease Network Investigators' Group), Canada.

Isabelle F Vonder Muhll (IFV)

Division of Cardiology, Department of Internal Medicine, Mazankowski Alberta Heart Institute, University of Alberta Hospital, Edmonton, Alberta, Canada; iCACH Net Group (Canadian Adult Congenital Heart Disease Network Investigators' Group), Canada.

Ariane J Marelli (AJ)

McGill Adult Unit for Congenital Heart Disease Excellence, Montréal, Québec, Canada; iCACH Net Group (Canadian Adult Congenital Heart Disease Network Investigators' Group), Canada. Electronic address: ariane.marelli@mcgill.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH